Skip to content
My WebMD Sign In, Sign Up

Non-Hodgkin's Lymphoma

Font Size

Vaccine May Help Fight Lymphoma

Vaccine Made From Patient's Own Tumor Cells Teaches Immune System to Fight Cancer

Most Patients Haven't Relapsed continued...

Characterizing the findings from the vaccine study as "persuasive", longtime lymphoma researcher Dan Longo, MD, of the U.S. National Institutes of Health, adds that there are many unanswered questions about the treatment.

First and foremost is whether the vaccination strategy will complement or interfere with the biologic drug Rituxan (rituximab), which works in a similar way by enlisting the immune system to fight cancercancer.

Rituximab along with chemotherapy is now considered a standard therapy for the treatment of aggressive lymphomas.

"If the observed remissions remain durable, the stage seems set for a head-to-head comparison between rituximab and [the targeted] vaccination as post-remission therapy in patients who achieve an initial chemotherapy-induced complete remission," Longo wrote in an editorial accompanying the study.

"If that comparison reveals a clear winner based on a disease-free survival endpoint, it may be time to consider putting in the effort to conduct a major study assessing overall survival," Longo said.


Today on WebMD

what is your cancer risk
Integrative Medicine Cancer Quiz
cancer fighting foods
Your Cancer Specialists Doctors You Need To Know

Vitamin D
New Treatments For Non-Hodgkins Lymphoma
Lifestyle Tips for Depression Slideshow
Pets Improve Your Health

WebMD Special Sections